Blog
Does This Proposed Stimulus Plan Offering $8,000 in Travel Tax Credits Stand a Chance of Passing?
If you're watching Washington eagerly for signs of another stimulus check, your head is probably swimming with all of the different proposals for providing more COVID-19 money.
With so many options
Why Sturm, Ruger Is Up 62% in the First Half of 2020
The same factors that mired Sturm, Ruger (NYSE: RGR) in a three-year slump between 2017 and 2019 are now behind what may turn out to be a tectonic shift that could last for several years.
Ruger
Why This One Stock Could Bring Life-Changing Returns
NVIDIA (NASDAQ: NVDA) has a record of outstanding growth, and with its share price close to all-time highs, some investors may be thinking it is already too late to get in. But looking at the
Need More Time to File Your Taxes This Year? Here's What You Need to Know
When the COVID-19 crisis exploded back in March, the IRS was quick to realize that Americans did not have the capacity to deal with taxes at a time when the entire country was suddenly grappling
More Than a Year After Its IPO, Are You Too Late to Buy Beyond Meat?
Beyond Meat (NASDAQ: BYND) has been a stock market superstar for most of its time as a publicly traded company. The maker of plant-based meat alternatives started out with a bang when its stock
Why Emergent BioSolutions Stock Soared 47% in the First Half of 2020
Shares of biopharmaceutical company Emergent BioSolutions (NYSE: EBS) gained 46.6% in the first half of 2020 (January to June), according to data from S&P Global Market Intelligence. The S&P 500
Can Cannabis 2.0 Products Boost Canopy Growth and Organigram in 2020?
There was a whole lot of hype after "Cannabis 2.0" happened in Canada in October 2019. It marked the second wave of recreational marijuana legalization in Canada. Cannabis 2.0 included cannabis
How to Prep Your Retirement Portfolio for a Second Wave
You've seen the news. COVID-19 is still taking its toll, to the extent that several states are closing up bars and restaurants, once again. You're right to worry about how a second wave might affect
Where Will Blue Apron Be in 5 Years?
Blue Apron (NYSE: APRN) burned a lot of investors after its IPO three years ago. The meal kit provider's stock, after being adjusted for a reverse split last year, currently trades more than 90%
Why Shares of iQiyi Rocketed 39.8% in June
Shares of iQiyi (NASDAQ: IQ) rose 39.8% in June, according to data from S&P Global Market Intelligence. iQiyi had traditionally been labeled the "Netflix (NASDAQ: NFLX) of China," but the truth was
Trash Is King: 3 Medical Waste Stocks Worth a Look
Medical waste was already a booming business before COVID-19, but the surge in coronavirus cases may accelerate the situation. Much of the personal protection equipment (PPE) that healthcare workers
3 Top Dividend Stocks to Buy in July
It would be nice to have a little bit of stability right now: in the economy, in the stock market, or just in general. But July is shaping up to be a very uncertain month this year. The normally
Macy's Charts a Coronavirus Recovery Path
Sales plunged 45% year over year at Macy's (NYSE: M) last quarter, as the COVID-19 pandemic caused it to close all its stores midway through the quarter. The weak sales results also forced the
Why Datadog Stock Surged 22% in June
Shares of IT monitoring software company Datadog (NASDAQ: DDOG) surged 22% in June, according to data from S&P Global Market Intelligence. The June performance was all the more impressive
Collecting Unemployment? You May Be in for This Financial Shock
Millions of Americans have lost their jobs in the wake of COVID-19, and for some, that means a loss of health insurance, as well as a paycheck. But not everyone gets health insurance through work
3 Large-Cap Stocks to Buy in July
While the COVID-19 pandemic has put many smaller companies in danger of going out of business, large companies with rock-solid balance sheets are looking good these days. In difficult times, big
Despite the Coronavirus, Exxon's Balance Sheet Remains Rock Solid
ExxonMobil's (NYSE: XOM) stock has fallen by more than a third so far in 2020, and its yield is up to a historically high 7.7%. There are very real issues facing this energy giant today, which is
No More Excuses -- Removing Obstacles to a Better Financial Future
Most of us are pretty good at coming up with excuses while we put off doing important things. Our tires might need more air, for example, but it looks like rain today, so maybe we'll aim to fill
Thinking of Taking a 401(k) Withdrawal? Here's What It Could Cost You
Withdrawing money from a 401(k) before age 59 1/2 is usually an extremely expensive proposition since you're hit with a 10% tax penalty on your early distribution.
The CARES Act aimed to change that
8 Stock Market Predictions for the Second Half of the Year
The first half of 2020 was a wild ride for investors.
What was barely a news story in the beginning of the year erupted into a global catastrophe as the coronavirus pandemic rocked investors around
Shares of Gilead Have Cooled Off: Is Now the Time to Buy?
At the end of April, shares of Gilead Sciences (NASDAQ: GILD) were hovering near their 52-week highs of $85.97. The stock has been falling since then, and it's now trading at just about $76. Year to
Inovio Stock: Buy, Sell, or Hold?
Inovio Pharmaceuticals (NASDAQ: INO) has been grabbing a lot of headlines over the past few weeks, mostly thanks to its involvement in the race to find a vaccine for COVID-19. The company claimed to
Your 3-Point Midyear Financial Checklist
It's been a rocky few months and an unquestionably difficult year for most of us thus far, but that doesn't change the fact that we're midway through 2020 and it's time to give your finances a
Why Uber's Stock Fell 14.4% in June
Uber (NYSE: UBER) saw its stock price decline by 14.4% in June, according to data provided by S&P Global Market Intelligence.
The ride-hailing company's shares remain flat year to date but are still
3 Top Medical-Device Stocks to Buy in the Second Half of 2020
Are you looking for a way to beat the market over the long run? You might want to seriously consider medical-device stocks.
Over the last five years, the medical-device sector has generated returns


